Cell and Gene Outsourcing
-
TARGATTâ„¢ iPSC Kits
9/30/2025
Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.
-
What Are The Keys To Making Rare Disease Drug Development Sustainable?
9/30/2025
This roundtable weaves together diverse perspectives, providing a multifaceted look at what it will take to create a sustainable path forward in rare disease drug development.
-
Manufacturing Strategies To Industrialize Autologous Therapies
9/30/2025
Discover how a systematic approach to autologous cell therapy manufacturing can reduce costs, improve reliability, and accelerate access to life-changing treatments.
-
Advanced iPSC Workflows: Accelerating Cell Therapy Development
9/30/2025
Beyond offering our GMP-compliant iPS cells, we develop superior workflows for gene editing and differentiation to provide competitive platforms to our partners and accelerate their therapeutic programs.
-
Improving Methodologies For iPSC Manufacturing And Differentiation
9/30/2025
Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.
-
CDNPs Enable Versatile, Rapid, And Robust T Cell Expansion For Scalable CAR-T Manufacturing
9/25/2025
Adopt next-generation, physiologic T cell activation strategies to enable faster, more consistent, and scalable CAR-T manufacturing that improves expansion, persistence, and patient access.
-
Small Molecule Analytical Testing Services
9/23/2025
In today’s dynamic regulatory environment, keeping pace with compliance requirements and advancements in small molecule analysis is essential.
-
Defining Strong Program Management In CDMO Partnerships
9/23/2025
This first article of a planned three-part series discusses the pitfalls that program managers help sponsor companies avoid, how program managers accelerate timelines or reduce risk, and more.
-
CGT Success Starts With The First Mile
9/23/2025
The so-called "last mile" in cell therapy gets a lot of attention. What about the first mile, the journey cells take between the donor and the manufacturing site?
-
IVD Regulatory Consulting Services
9/22/2025
With effective IVD regulatory consulting from an expert team, sponsors can transform challenges into competitive advantages and bring high-quality diagnostics to market more efficiently.